Presentations by Sessions

Speaker -Zoe Hughes-Thomas, Associate Director, Head Medicine Design Automation, GlaxoSmithKline

This presentation discusses the need for identification of exquisite specificities in therapeutic antibody discovery. It demonstrates GSK’s use of automation to keep the discovery funnel wider for longer. This includes the ability to express and purify panels of antibodies in a high-throughput, automated manner, enabling parallel screening for biological function and developability, accelerating the drug discovery process. I will describe how we have created data-rich environments to enable the selection of high-quality leads, accelerate cycle times to candidate and reduce the time on manual tasks freeing up FTEs to focus on science.

Chair: ,